TrademarkDir
SEBELA PHARMA RX DIRECT
LIVE

Serial Number

90615765

Owner

SEBELA IRELAND LIMITED

Attorney

David Chavous

First Use Date

Dec 1, 2022

Filing Date

Mar 31, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SEBELA PHARMA RX DIRECT Trademark

Serial Number: 90615765 • Registration: 7580255

SEBELA PHARMA RX DIRECT is a trademark filed by SEBELA IRELAND LIMITED on March 31, 2021. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SEBELA IRELAND LIMITED (31 trademarks)

ADELAIDE CHAMBERS, PETER STREET
DUBLIN 8 , IE

Entity Type: 11

SEBELA PHARMA RX DIRECT LLC

60 COLUMBIAN STREET WEST
BRAINTREE, MA 02184

Entity Type: 16

BRAINTREE LABORATORIES, INC. (65 trademarks)

BRAINTREE, MA 02184

Entity Type: 03

Trademark Details

Filing Date

March 31, 2021

Registration Date

November 26, 2024

First Use Anywhere

December 1, 2022

First Use in Commerce

December 1, 2022

Published for Opposition

May 9, 2023

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 16, 2024 ERRR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 16, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 15, 2024 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2024 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 23, 2024 SUPC
SOU EXTENSION 1 GRANTED
Jan 23, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 23, 2024 AITU
USE AMENDMENT FILED
Jan 4, 2024 IUAF
SOU EXTENSION 1 FILED
Jan 4, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 4, 2024 EEXT
TEAS STATEMENT OF USE RECEIVED
Jan 4, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 4, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 9, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 9, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 6, 2023 ERFR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 11, 2023 ASGN
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 5, 2022 GNFN
FINAL REFUSAL E-MAILED
Dec 5, 2022 GNFR
FINAL REFUSAL WRITTEN
Dec 5, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2022 CRFA
ASSIGNED TO LIE
Nov 30, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2022 CRFA
ASSIGNED TO LIE
May 17, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2022 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2022 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2021 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 19, 2021 ASGN
NEW APPLICATION ENTERED
Apr 3, 2021 NWAP

Related Trademarks

More from this Owner

NAVGI360

NAVGI360

S logo

S

S logo

S

S logo

S

S SEBELA PHARMACEUTICALS logo

S SEBELA PHARMACEUTICALS

S SEBELA PHARMACEUTICALS logo

S SEBELA PHARMACEUTICALS